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Problems in diagnostics of primary aldosteronism
— analysis of the own data
Trudności diagnostyki pierwotnego aldosteronizmu — analiza materiału własnego
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Abstract
Introduction: During the last few years, increasing evidence suggests that primary aldosteronism is the cause of over 10% of arterial
hypertension (AH). There are no “gold standard” methods for PA screening. The aim of study was plasma renin activity (PRA), plasma
aldosterone concentration (PAC), and ARR assessment as criteria for diagnosis of PA and their usefulness in clinical practice.
Material and methods: Eighty-one consecutive patients were admitted for diagnosis of primary aldosteronism: 51 women and 30 men,
aged 31–69 years. In each patient, PAC and PRA were evaluated by radioimmunoassay. In 65 patients, urine concentration of catecholami-
ne metabolites was assayed, and in 51 patients, diagnostics for hypercortisolaemia was carried out. In patients with adrenal incidentaloma,
16-row computer tomography was performed.
Results: The proportion of patients with PAC over 150 pg/ml was 35% (n = 28). The number of patients with PRA under 0.07 ng/ml/h was
19 (n = 15). The ratio of patients whose values of ARR exceeded over 20, 30, 40, 50, and 180 were 55, 47, 37, 28, and 15%, respectively.
Conclusions: The most common indication for primary screening was the presence of incidentally found adrenal mass. The quotient of
plasma aldosterone concentration/plasma renin activity at whichever cut-off point is not effective enough for the selection of patients for
further diagnostics or its cessation. (Pol J Endocrinol 2010; 61 (1): 2–5)
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Streszczenie
Wstęp: W kilku ostatnich latach pojawiła się znaczna liczba doniesień sugerujących, że pierwotny aldosteronizm stanowi przyczynę
ponad 10% przypadków nadciśnienia tętniczego (AH, arterial hypertension). Nie dysponujemy obecnie metodami skriningowymi pierwot-
nego aldosteronizmu (PA, primary aldosteronism), które można uznać za “złoty standard”. Celem pracy była ocena reninowej aktywności
osocza (PRA, plasma renin activity), stężenia aldosteronu w osoczu (PAC, plasma aldosterone concentration), wskaźnika aldosteron–renina
(ARR, aldosterone–renin ratio) jako kryteriów rozpoznania PA i określenie ich przydatności w praktyce klinicznej.
Materiał i metody: W badaniu wzięło udział 81 kolejnych pacjentów przyjetych w celu diagostyki PA: 51 kobiet i 30 mężczyzn w wieku
31–69 lat. U każdego chorego oznaczono PAC i PRA metodą radioimmunologiczną. U 65 pacjentów określono stężenie metabolitów
katecholamin w moczu. U 51 przeprowadzono diagnostykę w kierunku hiperkortyzolemii. U pacjentów z incidentaloma nadnerczy wyko-
nano 16-rzędową tomografię komputerową.
Wyniki: Odsetek pacjentów z PAC > 150 pg/ml wynosił 35% (n = 28), zaś z PRA < 0,07 ng/ml/h 19% (n = 15). Wartości ARR przekracza-
jące kolejne punkty odcięcia 20, 30, 40, 50 i 180 stwierdzono u odpowiednio 55, 47, 37, 28 i 15% badanych.
Wnioski: Najczęstszym wskazaniem do skriningu w kierunku pierwotnego aldosteronizmu stanowiła obecność przypadkowo wykryte-
go guza nadnerczy. Iloraz aldosteronemii do aktywności reninowej osocza, bez względu na przyjęty punkt odcięcia, nie stanowi wystar-
czającego kryterium, będącego podstawą do prowadzenia dalszej diagnostyki lub jej zaniechania.
(Endokrynol Pol 2010; 61 (1): 2–5)
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Introduction
Until recently, primary aldosteronism has been thought
a minor cause of arterial hypertension (AH). In recent
years an increasing number of cross-sectional and pro-
spective clinical studies have suggested that primary
aldosteronism (PA) is the cause of over 10% of AH [1–7].
In the case of forms of AH resistant to antihypertensive
agents, the proportion of patients is higher and reaches
11–22% [4, 5]. Confirmation of PA is the basis of the start
of diagnostic investigation for the reason for PA [6, 7].
The means of the treatment — surgical or pharmacological
— depends on the recognized cause of PA. The effecti-
veness of the adrenalectomy depends on early diagno-
sis and is measured by the proportion of normotensive
patients [8]. However, effective treatment by surgery
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or pharmacotherapy is also associated with elimination
of the negative influence of increased aldosterone le-
vels on the epithelium, vascular smooth muscles, and
in consequence on cardiovascular complications [9, 10].
The above data suggest an important place of screening
tests for PA in the diagnostic investigation of AH, espe-
cially in several patient groups: young, with severe hy-
pertension, drug-resistant AH, and AH with adrenal
incidentaloma and/or with spontaneous or diuretic-in-
duced hypokalaemia [1, 7]. The tests that are presently
used — plasma renin activity (PRA) and plasma aldo-
sterone concentration (PAC) — are exposed to high la-
boratory error, and low sensitivity and specificity. This
has led to the use of PAC/PRA quotient (ARR, aldoste-
rone–renin ratio) instead of PRA or PAC separately.
Unfortunately, the cut-off values for ARR in many mul-
tiple independent studies are different and are still con-
troversial because the range averages from 20 to 100 [1–
7, 11].Taking into account the above data, the objective
of the present work was the assessment of PRA, PCA,
and ARR as criteria for diagnosis of PA, and their use-
fulness in clinical practice.
Material and methods
This retrospective study was performed on 81 consecu-
tive patients hospitalized during the years 2006–2008
at the Clinical Department of Endocrinology UMB ad-
mitted in order to diagnose primary aldosteronism. This
group contained 51 women (63%) aged 57 ± 11.7 years
and 30 men (37%) aged 50 ± 19.2 years. In each patient,
plasma aldosterone and plasma renin activity, and na-
trium and kalium plasma concentrations were evalu-
ated. In 65 patients, urine concentration of catechola-
mine metabolites was assayed, and in 51 patients, dia-
gnostics for hypercortisolaemia was carried out. In pa-
tients with adrenal incidentaloma (AI), 16-row computer
tomography was performed with description of tissue
density in Hounsfield’s scale. Before determination of
PAC and PRA was performed, the deficiency of potas-
sium was compensated; diuretics and spironolactone
were withdrawn for at least 4 weeks, for 2 weeks:
b-adrenergic blockers, clonidine, methyldopa, dihydro-
piridine calcium channel antagonists, angiotensin
— converting enzyme inhibitors, angiotensin receptor
blockers, and nonsteroidal anti-inflammatory drugs.
PAC was determined by radioimmunoassay method
with RIAZENco kit ZenTech (Angleur, Belgium). The
value of CV was 5.3%, sensitivity 1.4 pg/ml, and specifi-
city 100%. PRA was assayed by radioimmunoassay
method with use of REN-CT2 kit of Radim Company
(Rome, Italy). The value of the CV test was 7.18%, sen-
sitivity 0.15 ng/ml, and specificity 100%. Determinations
of urine metanephrine and normetanephrine were per-
formed by immunoassay method using Nephrines Uri-
ne kits from  Biosource (Nivellas, Belgium). Value expec-
tations: metanephrines < 350 mg/day; normetanephri-
nes < 600 mg/day; Sensitivity: metanephrines 5 ng/Ml;
normetanephrines 13 ng/MI. CV for metanephrines
5.2%, for normetanephrines 12.2%. Cortisol was evalu-
ated by chemiluminescence method with Architect
System kits, Abbott company (Germany, Wiesbaden):
sensitivity £ 1 mg/dl, CV 20%.
Results
The indication to assay PRA and PAC was adrenal inci-
dentaloma (AI) in 50 patients (61.7%), drug-resistant
hypertension in 16 (19.7%), early-onset hypertension
(< 40 years) in 8 (9.9%), hypertension and hypokala-
emia in 4 (4.9%), and hypokalaemia without hyperten-
sion in 2 (2.5%). Figure 1 shows the prevalence of pa-
tients with particular indications to diagnosis of PA (with
reference to the whole group; n = 81) in which ARR
exceeded consecutive cut-offs. The ratio of patients
whose values of ARR exceeded over 20, 30, 40, 50, and
180 were 55, 47, 37, 28, and 15%, respectively.
The ratio of patients with plasma aldosterone con-
centration over 150 pg/ml is shown in Figure 2, and the
proportional rate of the patients with plasma renin ac-
tivity under 0.07 ng/ml/h is illustrated in Figure 3. Figu-
re 4 shows the ratio of patients in which the existence
of three criteria helpful in the diagnose of PA were de-
tected: ARR > 20, PAC > 150 pg/ml, PRA < 0.07 ng/ml/h
(n = 7) and the proportional rate of patients that had
hypokalaemia apart from the three criteria above (n = 4)
compared to the whole group (n = 81). In the group of
the patients in whom ARR > 180 (n = 12), in 9 (66.6%)
PAC > 150 pg/ml and PRA < 0.07 ng/ml/h was found
as well.
Discussion
The most numerous group of patients sent for PA scre-
ening in our study was the AI group. The majority of
IA patients appeared to have increased percentages of
elevated ARR, independently of the cut-off point. The
research indicated significantly increased PAC in every
third patient (35%) and considerably decreased PRA in
every fifth patient (19%). These ratios significantly exce-
ed the statistical population prevalence of PA as a cau-
se of hypertension. In every tenth of the examined pa-
tients (11%), the coexistence of three criteria suggesting
PA (ARR > 20, PAC > 150 pg/ml and PRA < 0.07 ng/ml/h)
were found. This percentage could reflect the popula-
tion prevalence of PA [1–7]. However, our experience
with the saline confirmation test (unpublished data)
shows that in some of the patients with all three of the
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above criteria present saline normalise PAC. In the gro-
up of patients who fulfilled the three criteria of PA, 4 of
the 11 additionally had hypokalaemia, which makes
diagnosis of PA more probable. However, hypokalaemia
is seen in the minority (9–37%) of PA cases [1–7, 11].
The ratio of patients whose values of ARR exceeded 20,
30, 40, 50, and 180 was 55, 47, 37, 28, and 15%, respective-
ly. However, PAC > 150 pg/ml and PRA < 0.07 ng/ml/h
coexisted only in two-thirds of patients with significan-
tly increased ARR > 180. Moreover, even a cut-off va-
lue of ARR=180 was exceeded by 15% of the values.
On one hand, this data suggests a significant ratio of
false positive rates of ARR at whichever ARR cut-off
point, when the statistics of PA in hypertension are ta-
ken into account. On the other hand, significantly in-
creased ARR probably does not constitute certain dia-
gnosis of PA. In the PAPY study, positive rates of ARR
at a cut-off point of 40 were observed in 20% of AH
patients [1]. In our study, 37% of patients had positive
rates at this cut-off level. In the study by Nishizaka et al.,
positive rates were noticed in 69% of cases at ARR = 20
as an optimal (sensitivity and specificity about 80%) [11].
In our analysis, in 55.5% of patients, this criterion was
present. It is necessary to take into account the fact that
mathematically PRA affects the PAC/PRA ratio to a fur-
ther degree than PAC, as far as PRA could range from
Figure 1. Ratio of patients’ particular indications to diagnose primary aldosteronism (in comparison to the whole group; n = 81) in
which plasma aldosterone to renin ratio exceeded consecutive cut-offs
Rycina 1. Procentowe występowanie poszczególnych wskazań do diagnostyki w kierunku pierwotnego aldosteronizmu (w porównaniu
z całą grupą n = 81) w zależności od wartości odcięcia wskaźnika aldosteron–renina
Figure 2. The rate of the patients with plasma aldosterone
concentration over 150 pg/ml
Rycina 2. Odsetek chorych, u których stężenie aldosteronu
w osoczu przekraczało 150 pg/ml
Figure 3. Proportional rate of patients with plasma renin activity
under 0.07 ng/ml/h
Rycina 3. Odsetek chorych, u których reninowa aktywność osocza
wynosiła poniżej 0,7 ng/ml/h
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hundredth hundredths to dozens (4 classes of size) and
PAC from dozens to several hundred (2 classes of size).
Moreover, lower values of PRA are more frequently seen
in patients over 65 [7, 12]. To prevent pre-laboratory
mistakes in PAC/PRA determination it is necessary to
correct the deficiency of potassium, withdraw diuretics
and spironolactone for at least 4 weeks, and b-adrener-
gic blockers, clonidine, methyldopa, dihydropiridine
calcium channel antagonists, angiotensin–converting
enzyme inhibitors, angiotensin receptor blockers, and
nonsteroidal anti-inflammatory drugs (elevation PAC/
/PRA) for 2 weeks. ARR should be evaluated in blood
samples collected at mid-morning, after the patient has
been up for at least 2 hours and seated for 5–15 minutes
[6, 7]. Antihypertensive medications of lesser effect on
the ARR are verapamil, hydralazine, and b-adrenergic
blockers (prazosin, doxazosin, terazosin). Our data sug-
gest the necessity of using confirmatory tests indepen-
dently of the chosen cut-off points. Confirmation of PA
may be obtained by methods that enable verification of
the autonomic character of aldosterone secretion: oral
or intravenous tests of sodium loading or fludrocorti-
sone [7, 12]. The captopril test is not recommended be-
cause of the diverse influence on PAC in the group of
patients with adrenal hyperplasia and adrenal adeno-
ma [7]. Early diagnosis of PA caused by unilateral change
(majority of PA) and further adrenalectomy (preferable
in endoscopic approach) gives the patient a higher chance
for normotension without antihypertensive medication.
Significant factors of effectiveness of surgical treatment
also include age, gender, and tumour size [8, 13, 14].
Waltz et al. observed 40% effectiveness of surgical tre-
atment at patients with £ 5 years duration of hyper-
tension v. 24% when that time was longer, 42% of
effectiveness in a group of patients aged £ 50 years
v. 15% who were elderly and 42% of females v. 16% at
males [8].
In summary, on one hand, increased availability of
diagnostic methods (mainly ultrasonography) that
make diagnosis of AI easier, the growing prevalence of
hypertension in patients with metabolic syndrome, and
the awareness of the more frequent causative role of
PA in HA based on recently published studies incre-
ases the number of patients sent to be diagnosed for
PA. On the other hand, there are no “gold standard”
screening tests of satisfactory specificity and sensitivi-
ty, which makes PA diagnosis difficult and equivocal.
Conclusions
1. The most common indication for case detection of
primary aldosteronism was the presence of inciden-
tally found adrenal gland tumours.
2. The quotient of plasma aldosterone concentration/
/plasma renin activity at whichever cut-off point is
not effective enough to select patients for further
diagnostics.
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Figure 4. The rate of patients in which 3 criteria helpful to diagnose
PA were detected: ARR > 20, PAC > 150 pg/ml, PRA < 0.07 ng/
/ml/h (n = 7) and percentage of the patients with 3 criteria and
hypokalaemia (n = 4) compared to the whole group (n = 81)
Rycina 4. Odsetek chorych, u których stwierdzono 3 kryteria
pomocne w rozpoznaniu PA: ARR > 20, PAC > 150 pg/ml, PRA
< 0,07 ng/ml/h (n = 7) oraz odsetek chorych, u których
stwierdzono 3 kryteria i hipokaliemię (n = 4) w porównaniu
z całą grupą (n = 81)
